BIO-PATH HOLDINGS, INC. - Common Stock (BPTH)

CUSIP: 09057N409

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
604,749
Total 13F shares
142,633
Share change
+123,566
Total reported value
$285,096
Price per share
$2.00
Number of holders
13
Value change
+$246,952
Number of buys
6
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 09057N409?
CUSIP 09057N409 identifies BPTH - BIO-PATH HOLDINGS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIO-PATH HOLDINGS, INC. - Common Stock (BPTH) as of Q2 2024

As of 30 Jun 2024, BIO-PATH HOLDINGS, INC. - Common Stock (BPTH) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 142,633 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, HRT FINANCIAL LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), BlackRock Inc., UBS Group AG, Qube Research & Technologies Ltd, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY. This page lists 13 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.